Section Arrow
TMDX.NASDAQ
- TransMedics Group
Quotes are at least 15-min delayed:2024/05/16 22:13 EDT
Last
 134.93
-1.21 (-0.89%)
Day High 
136.04 
Prev. Close
136.14 
1-M High
137.59 
Volume 
822.38K 
Bid
134
Ask
137.48
Day Low
133.6 
Open
136.04 
1-M Low
82.87 
Market Cap 
4.48B 
Currency USD 
P/E -- 
%Yield
10-SMA 129.9 
20-SMA 111.33 
50-SMA 93.34 
52-W High 137.59 
52-W Low 36.4201 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.34/0.27
Enterprise Value
5.00B
Balance Sheet
Book Value Per Share
4.84
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
23.60M
Operating Revenue Per Share
5.82
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SINTSiNtx Technologies0.14+0.0124+9.72%-- 
HSCSHeart Test Laboratories0.1131+0.0232+25.81%-- 
ZOMZomedica Corp0.1843+0.0151+8.92%-- 
PACBPacific Biosciences of California2.19+0.045+2.10%-- 
CATXPerspective Therapeutics1.53-0.04-2.55%-- 
Quotes are at least 15-min delayed:2024/05/16 22:13 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.